Sep 15, 2025, 08:42
W. Alberto Sifuentes Giraldo Highlights 4-Fold Higher Preeclampsia Risk in Pregnant SLE Patients with LN and APS
W. Alberto Sifuentes Giraldo, Rheumatologist at Hospital Nuestra Señora de Sonsoles (Sacyl), has shared a post on LinkedIn:
“Pregnant women with systemic lupus erythematosus (SLE) face a substantially higher risk of preeclampsia (PE) and PE with severity criteria, with both lupus nephritis (LN) and antiphospholipid syndrome (APS) emerging as strong, independent risk factors for these complications, as confirmed by a Spanish nation-wide cohort study:
- LN and APS nearly double PE risk beyond SLE by itself. Both conditions potentiate each other, since the combination of LN and APS results in a 4-fold higher risk of PE compared with SLE women without any of them.
- Renal involvement in SLE confers a high likelihood of developing PE, particularly in the more severe forms; LN independently triples PE with severity criteria odds.
These findings indicate that LN, and APS should be a fundamental factor in pre-conceptional planning, PE risk stratification, pregnancy monitoring, and prognostic assessment of PE in SLE patients.”

More insights on Hemostasis Today.
-
Sep 18, 2026, 11:10R. Stephani Hellwege: Beyond LVEF Echocardiographic Assessment of Undifferentiated Shock
-
Sep 18, 2026, 06:48Gopal Patidar: Honoured to Contribute to the ASFA 2026 Guidelines for Therapeutic Apheresis
-
Sep 18, 2026, 05:48Julie Taylor: Navigating Tech Glitches to Deliver Engaging BBTS Presentation
-
Sep 18, 2026, 05:42Emma Copperwaite: BBTS Conference Presentation Highlights Power of Peer Support and Pushing Past Fear
-
Sep 18, 2026, 05:34Suhasini Sil: RGSSH Joins Mega Blood Donation Camp at Thyagaraj Stadium
-
Sep 18, 2026, 05:25Lisa Laun: Spleen Clears Activated Platelets to Limit Thrombosis and Inflammation
-
Sep 18, 2026, 05:16Louise St. Germain Bannon: ISTH Advocates for Enhanced Patient Safety in Blood Disorder Care
-
Sep 18, 2026, 05:08Vikas Veer: Exploring Sickle Cell Anemia at the Molecular Level
-
Sep 18, 2026, 01:35Matthew Hazell: From Platelet Refractoriness to Protecting Transplanted Organs